Embody review

These are among the lowest published monthly figures of any provider here, and two things need saying before a reader treats them that way. The first is the banner: the site announces a summer promotion already applied to the prices shown, and quantifies the saving at a sum larger than either price. That makes both figures promotional, and the rate they revert to is not printed anywhere — so a reader can see what the first months cost and cannot see what the year costs. The second is what the products are called. Embody labels them by receptor rather than by drug, selling a GLP-1 injection and a GLP-1 with GIP injection. In this category a dual agonist at that price point is nearly always tirzepatide, but nearly always is an inference and the page does not make the statement, so this review does not make it either. That matters more here than it would elsewhere, because the reason to know the molecule is to know what dose you are holding and what a small one ought to cost. Neither figure carries a milligram in any case. What the site does state plainly deserves credit: the medication is inside the price rather than billed beside it, there is no membership, and a patient already on treatment elsewhere can transfer at their current dose if they can show the prescription — a genuinely useful policy for someone who has titrated down and wants to stay there rather than restart a ladder.

Vs median

$96/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

Embody does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

These are among the lowest published monthly figures of any provider here, and two things about them need saying before a reader treats them that way. The first is the banner: the site announces a summer promotion already applied to the prices shown, and quantifies it at a sum larger than either price. That makes both figures promotional, and the rate they revert to is not printed anywhere — so a reader can see what the first months cost and cannot see what the year costs. The second is what the products are called. Embody labels them by receptor rather than by drug, selling a GLP-1 injection and a GLP-1/GIP injection. In this category a dual agonist at that price point is nearly always tirzepatide, but nearly always is an inference and the page does not make the statement, so this row does not make it either. That matters more here than it would elsewhere, because the whole reason to know the molecule is to know what dose you are holding and what a small one should cost. Neither figure carries a milligram anyway. What the site does state plainly is worth the credit: the medication is inside the price rather than billed beside it, there is no membership, and a patient already on treatment elsewhere can transfer at their current dose if they can show the prescription — which is a genuinely useful policy for someone who has titrated down and wants to stay there rather than restart a ladder.

Both figures are promotional and the standing rate is published nowhere.

• Neither product names its molecule — they are labeled by receptor only.
• No dose sits behind either figure, and both are written as a starting point.

Embody is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Microdosing tirzepatide
• Is compounded GLP-1 safe?
• The true annual cost of a plan
• What a flat price costs at a low dose